Aklima Akter

1.1k total citations · 1 hit paper
16 papers, 736 citations indexed

About

Aklima Akter is a scholar working on Molecular Biology, Complementary and alternative medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Aklima Akter has authored 16 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Complementary and alternative medicine and 3 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Aklima Akter's work include Medicinal Plants and Neuroprotection (3 papers), Phytochemicals and Antioxidant Activities (3 papers) and Natural Antidiabetic Agents Studies (3 papers). Aklima Akter is often cited by papers focused on Medicinal Plants and Neuroprotection (3 papers), Phytochemicals and Antioxidant Activities (3 papers) and Natural Antidiabetic Agents Studies (3 papers). Aklima Akter collaborates with scholars based in Bangladesh, Egypt and India. Aklima Akter's co-authors include Fahadul Islam, Talha Bin Emran, Mohamed H. Nafady, Md. Rezaul Islam, Saikat Mitra, Simona Cavalu, Sheikh Shohag, Arpita Roy, Fahad A. Alhumaydhi and Ghulam Md Ashraf and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and BioMed Research International.

In The Last Decade

Aklima Akter

15 papers receiving 708 citations

Hit Papers

Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NP... 2022 2026 2023 2024 2022 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications
    2022 249 citations Fahadul Islam, Sheikh Shohag et al. Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aklima Akter Bangladesh 12 177 162 89 86 70 16 736
Mohamed H. Nafady Egypt 12 180 1.0× 229 1.4× 73 0.8× 73 0.8× 72 1.0× 28 842
Sheikh Shohag Bangladesh 9 191 1.1× 274 1.7× 71 0.8× 95 1.1× 77 1.1× 18 874
Minyan Dang China 16 113 0.6× 198 1.2× 72 0.8× 86 1.0× 75 1.1× 35 723
Ömer Hazman Türkiye 18 125 0.7× 205 1.3× 108 1.2× 165 1.9× 58 0.8× 60 914
Manal Abudawood Saudi Arabia 16 264 1.5× 192 1.2× 68 0.8× 127 1.5× 59 0.8× 55 903
Remus Moldovan Romania 15 114 0.6× 138 0.9× 49 0.6× 69 0.8× 70 1.0× 66 638
Ruxia Wang China 16 127 0.7× 255 1.6× 50 0.6× 101 1.2× 52 0.7× 32 831
Olusola Bolaji Adewale Nigeria 15 194 1.1× 277 1.7× 97 1.1× 154 1.8× 124 1.8× 61 900
Nicoleta Decea Romania 14 138 0.8× 127 0.8× 64 0.7× 66 0.8× 93 1.3× 44 652
Yun Sun China 21 121 0.7× 257 1.6× 53 0.6× 130 1.5× 88 1.3× 35 1.0k

Countries citing papers authored by Aklima Akter

Since Specialization
Citations

This map shows the geographic impact of Aklima Akter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aklima Akter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aklima Akter more than expected).

Fields of papers citing papers by Aklima Akter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aklima Akter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aklima Akter. The network helps show where Aklima Akter may publish in the future.

Co-authorship network of co-authors of Aklima Akter

This figure shows the co-authorship network connecting the top 25 collaborators of Aklima Akter. A scholar is included among the top collaborators of Aklima Akter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aklima Akter. Aklima Akter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Akter, Aklima, et al.. (2025). Exosomes: a potential tool in the diagnosis, prognosis and treatment of patients with colorectal cancer. Future Oncology. 21(18). 2347–2365. 1 indexed citations
3.
Rahman, Md. Mominur, Md. Rezaul Islam, Md. Mohaimenul Islam, et al.. (2022). Emerging Role of Neuron‐Glia in Neurological Disorders: At a Glance. Oxidative Medicine and Cellular Longevity. 2022(1). 3201644–3201644. 40 indexed citations
4.
Islam, Fahadul, Manish Dhawan, Mohamed H. Nafady, et al.. (2022). Understanding the omicron variant (B.1.1.529) of SARS-CoV-2: Mutational impacts, concerns, and the possible solutions. Annals of Medicine and Surgery. 78. 103737–103737. 36 indexed citations
5.
Mitra, Saikat, Fahadul Islam, Rajib Das, et al.. (2022). Pharmacological Potential of Avicennia alba Leaf Extract: An Experimental Analysis Focusing on Antidiabetic, Anti‐inflammatory, Analgesic, and Antidiarrheal Activity. BioMed Research International. 2022(1). 7624189–7624189. 20 indexed citations
6.
Islam, Fahadul, Md. Harun-Or-Rashid, Md. Saidur Rahaman, et al.. (2022). Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2022(1). 5100904–5100904. 59 indexed citations
7.
Islam, Fahadul, Mohamed H. Nafady, Md. Rezaul Islam, et al.. (2022). Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside. Molecular Neurobiology. 59(7). 4384–4404. 64 indexed citations
8.
Islam, Fahadul, Saikat Mitra, Mohamed H. Nafady, et al.. (2022). Neuropharmacological and Antidiabetic Potential of Lannea coromandelica (Houtt.) Merr. Leaves Extract: An Experimental Analysis. Evidence-based Complementary and Alternative Medicine. 2022. 1–10. 53 indexed citations
9.
Akter, Aklima, Fahadul Islam, Md. Al-Amin, et al.. (2022). CNS depressant activities of Averrhoa carambola leaves extract in thiopental-sodium model of Swiss albino mice: implication for neuro-modulatory properties. Biologia. 77(5). 1337–1346. 41 indexed citations
10.
Islam, Fahadul, Aklima Akter, Anjuman Ara Mimi, et al.. (2022). Neuropharmacological Effects of Chassalia curviflora (Rubiaceae) Leaves in Swiss Albino Mice Model.. SHILAP Revista de lepidopterología. 77(2). 881–890. 11 indexed citations
11.
Islam, Md. Rezaul, Fahadul Islam, Mohamed H. Nafady, et al.. (2022). Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint. Molecules. 27(7). 2165–2165. 101 indexed citations
12.
Islam, Fahadul, Sheikh Shohag, Md. Rezaul Islam, et al.. (2022). Exploring the Journey of Zinc Oxide Nanoparticles (ZnO-NPs) toward Biomedical Applications. Materials. 15(6). 2160–2160. 249 indexed citations breakdown →
13.
Islam, Fahadul, Md. Rezaul Islam, Sheikh Shohag, et al.. (2022). Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus. Evidence-based Complementary and Alternative Medicine. 2022. 1–16. 26 indexed citations
14.
Akter, Aklima, et al.. (2019). Quality Analysis of Different Marketed Brands of Carbamazepine Available in Bangladesh. 1 indexed citations
15.
Akter, Aklima, et al.. (2018). A survey on dental problems and awareness on dental health among Bangladeshi people. 93–100. 3 indexed citations
16.
Khan, Muhammad Shamim, et al.. (2010). Screening of ethanol, petroleum ether and chloroform extracts of medicinal plants, Lawsonia inermis L. and Mimosa pudica L. for antibacterial activity. Indian Journal of Pharmaceutical Sciences. 72(3). 388–388. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mohamed H. Nafady Breakdown of academic impact, for papers by Sheikh Shohag Breakdown of academic impact, for papers by Minyan Dang Breakdown of academic impact, for papers by Ömer Hazman Breakdown of academic impact, for papers by Manal Abudawood Breakdown of academic impact, for papers by Remus Moldovan Breakdown of academic impact, for papers by Ruxia Wang Breakdown of academic impact, for papers by Olusola Bolaji Adewale Breakdown of academic impact, for papers by Nicoleta Decea Breakdown of academic impact, for papers by Yun Sun
Rankless by CCL
2026